Business Wire

Veza, the Data Security Platform Built on the Power of Authorization, Announces Partnership with Google Cloud

19.7.2022 16:00:00 EEST | Business Wire | Press release

Share

Veza, the data security platform built on the power of authorization, announces today that the company has entered a partnership with Google Cloud, including product integration that enables Google Cloud customers to harness the capabilities of Veza’s data security platform across their multi-cloud ecosystem.

Veza, which recently launched in April 2022 after two years of building in stealth, makes it easy to understand, manage, and control who can and should take what action on what data. With this new integration, Google Cloud customers can now directly access the capabilities of Veza’s authorization-based data security platform integrated with Google Cloud Policy Analyzer to identify, manage, and control external identities and service accounts to Google Cloud services (Looker, BigQuery, and more). This partnership furthers the relationship between Google and Veza, which began in 2021 when GV led the Series B investment in Veza and GV Partner Karim Faris joined Veza Board of Directors.

“The cloud is quickly becoming the primary footprint for organizations. By prioritizing and investing in security, Google Cloud has earned a differentiated position in the market,” said Tarun Thakur, Co-founder and CEO, Veza. “The initial product integration between Veza and Google Cloud, publicly demonstrated at the Google Cloud Security Summit in May this year, is a powerful example of how intelligence from Veza’s Authorization Graph can bolster the data security of Google Cloud customers. It shows how identity-to-data relationship insights from the Veza platform can be pulled directly into the Google Cloud Policy Analyzer, allowing customers to secure both Google Cloud data (Looker, BigQuery, Google Storage Buckets, etc.) to which multi-cloud identities (AD, Azure AD, Okta, etc.) have permissions and multi-cloud data (AWS, Snowflake, etc.) that is being accessed by Google Cloud identities.”

“Securing cloud environments and data from cybercrime and threats is a key priority of organizations across the globe,” said Sunil Potti, General Manager and Vice President, Cloud Security, Google Cloud. “With Veza’s platform now available alongside Google Cloud’s secure and global infrastructure, customers will be able to quickly deploy the solutions they need to better understand, control, and securely take action on their data across their multi-cloud environments.”

Veza’s data security platform aggregates identity information from humans, service accounts, and cloud IAM entities, and authorization data from apps and data systems, giving organizations a centralized, SaaS-based control plane to visualize, manage, and control data access controls through Veza’s Authorization Graph. Veza integrates with cloud identity providers, SaaS and custom apps, and data systems, and translates system-specific entitlements and permissions into a common, human-understandable business language, visualized in the platform as effective permissions. The platform brings a novel approach to data security by enabling organizations to address key data security use cases across access reviews and certifications for SaaS apps and data systems, privileged access management to data and apps, data lake security and governance, management of cloud entitlements, and much more. It delivers prioritized insights, provides access workflows, and actionable recommendations for remediation of over-privileged accounts, enabling security and IT teams to correct anomalies and right-size their organization’s permissions to protect against ransomware and other data breaches.

As organizations continue to adapt to the evolving demands of hybrid remote and in-office work, multi-cloud and hybrid-cloud environments — those with multiple providers of disparate data, app, compute, and infrastructure systems — are becoming the norm. According to the Flexera 2022 State of the Cloud Report, 89% of companies surveyed are multi-cloud, with only 2% operating in single private clouds and 9% in single public clouds. This trend is leading to a distributed web of data, relationships, and access points that are changing and difficult to track and secure.

Veza and Google Cloud already have a number of joint customers deployed across the industries of SaaS software, marketing technology, and media, including Vox Media.

“To support Vox Media’s growth and increasing M&A activity without compromising security, we need to ensure that across all of our brands, the right users have access only to the data they need access to, and that we have full visibility over what they can do with that data,” says Ateeb Ahmad , Senior Director, IT Infrastructure, Vox Media. With Veza and Google Cloud working together, we’ve been able to seamlessly manage access controls over our data for our largest merger to date, and tightly scope identity-to-data permissions even as our footprint with Google Cloud and other technologies grows.”

“The greatest gifts of the multi-cloud and the generational architectural shift of the modern data systems are also its greatest risks: securing data, scalability, flexibility, and seamless collaboration,” says Thakur. “When organizations enable workers to reach from one cloud to another to leverage data across their entire multi-cloud ecosystem, they foster growth, enable more intelligence, and promote agility. However, such apps and data systems are also more porous and are at increased risk of cybercrime and ransomware. We purpose-built Veza’s Core Authorization Platform for the multi-cloud so that organizations can implement strong access governance policies - Veza continuously evaluates these policies and enables both automated workflows for access reviews, automated access removal for toxic and stale combinations, and facilitates access grant and request for any app, data, and service.”

Learn More:

Google Cloud Security Summit - Best practices for defining and enforcing policies across your Google Cloud environment

Veza for Google Cloud demo
Veza for Google Cloud
Veza Free Trial - sign up here

About Veza

Veza is the data security platform built on the power of authorization. Our platform is purpose-built for hybrid multi-cloud environments to help you use and share your data safely. Veza makes it easy to understand, manage, and control who can and should take what action on what data. We organize authorization metadata across identity providers, data systems, cloud service providers, and SaaS applications — all to address the toughest data security challenges of the modern era. Founded in 2020, the company is funded by top-tier investors including Accel, Bain Capital, Ballistic Ventures, Blackstone, GV, Norwest Venture Partners, and True Ventures. To learn more, please visit us at veza.com. You can follow us on LinkedIn or on Twitter @vezainc.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Aircover PR
veza@aircoverpr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Rapid Medical™’s TIGERTRIEVER™ 13 Demonstrates Promising 90-Day Outcomes in DISTALS Trial, Reinforcing Pivotal Safety and Efficacy Findings7.5.2026 15:03:00 EEST | Press release

Rapid Medical™, a leading developer of advanced stroke treatment devices, today announced full results from the DISTALS randomized clinical trial, presented at the 11th European Stroke Organisation Conference (ESOC) in Maastricht, Netherlands, showing that TIGERTRIEVER™ 13 can safely restore blood flow to the brain and may improve clinical outcomes in patients with distal and medium vessel occlusion (DMVO) stroke. These findings build on earlier results showing a threefold improvement in restoring blood flow compared with medical management alone (p<0.0001), with no cases of serious brain bleeding observed in the treatment group. “These results show we can now safely restore blood flow and suggest this will make a meaningful difference for the right patients,” said Jeffrey L. Saver, MD, UCLA, and Principal Investigator of DISTALS. “What’s important is that both the device and the trial were designed specifically for distal stroke. By using a device built for these small vessels and mea

2 Million Downloads in Six Months: Tabelog’s Multilingual App Solves Critical Dining Pain Points for Travelers to Japan7.5.2026 15:00:00 EEST | Press release

Tabelog (https://tabelog.com/en/), one of Japan’s largest (*1) restaurant search and reservation services operated by Kakaku.com, Inc., has announced that its multilingual smartphone app (iOS/Android) for travelers visiting Japan has reached 2 million downloads (*2). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507560248/en/ 2M+ Downloads in 6 Months. The app also ranked #1 in downloads among Restaurant Search Apps in Japan for International Travelers (*3) in Taiwan, Hong Kong, South Korea, and the U.S., reflecting its immense popularity among global visitors. Download URL: https://tabelog-tourists.onelink.me/3eEh/iqkkho9r The Trusted Choice for Global Travelers: Solving Two Major Dining Pain Points in Japan For years, international visitors to Japan have faced two critical dining pain points: [Pain Point 1] The Information Gap: Most available resources are tailored for tourists, making it difficult to find the true loc

Altasciences and Certara Announce Strategic Partnership to Accelerate Early Drug Development7.5.2026 15:00:00 EEST | Press release

Altasciences, a fully integrated drug development solution company, andCertara (Nasdaq: CERT), a global leader in model-informed drug development (MIDD), today announced a strategic partnership to accelerate early-phase development programs. Fewer than half of preclinical drug candidates successfully reach first-in-human trials. Failures are driven by toxicity, poor pharmacokinetics, lack of efficacy, and challenges translating results from animals to humans. Many of these risks can be mitigated through a fully integrated model-informed drug development approach. Building on Altasciences’ Acceleration Platform, the integration of Certara’s strategic drug development services and biosimulation technology enables sponsors to establish proof of mechanism earlier, design more efficient studies, and make informed go/no-go decisions with greater confidence. By embedding modeling insights and digital workflows directly into development execution, study designs are optimized, dosing strategies

FIFA and Fanatics Expand Wide-Ranging Relationship to Include Historic Exclusive Collectibles Agreement (Trading Cards, Stickers and Trading Card Games)7.5.2026 14:00:00 EEST | Press release

In a landmark agreement expanding their already successful wide-ranging commercial relationship, FIFA and Fanatics have signed a long-term, exclusive collectibles licensing deal that features trading cards, stickers, and trading card games. The agreement, which will begin in full in 2031, covers both physical and digital collectibles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260507105628/en/ An example of the product innovations that will be brought to fans under this new partnership is the highly sought-after player jersey patch program, including debut patches, which will be inserted into football trading cards from 2031 onward. All products will be designed and developed through Fanatics Collectibles and produced under the Topps brand. As a part of the deal, Fanatics will bring the magic to young people in every region of the world and support youth football globally by distributing more than $150 million in collect

DEFINITIVE Trial Reaches Major Milestone: All Centres Approved and More Than 50% Recruitment Achieved7.5.2026 12:21:00 EEST | Press release

The DEFINITIVE project, a landmark European Union-funded international phase III clinical trial evaluating the use of the HER2DX diagnostic assay to guide personalised treatment in early-stage HER2-positive breast cancer (BC), announces two major operational milestones at the ESMO Breast Cancer 2026 congress. Approvals have been obtained in the 7 participating countries, 33 clinicals sites are now open for patient recruitment. The trial has reached over 50% of its recruitment target, marking a pivotal moment on the path toward to transforming HER2-positive BC treatment. About the DEFINITIVE Project The DEFINITIVE project is a 5-year, prospective, open-label, randomised, two-arm phase III international clinical trial conducted across 44 centres in 7 European member states and associated countries. The trial aims to demonstrate that personalising treatment decisions for patients with early-stage (stage II to IIIA) HER2-positive BC using the HER2DX genomic diagnostic assay can improve pat

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye